Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Insight Molecular Diagnostics (IMDX) Income from Continuing Operations: 2020-2025

Historic Income from Continuing Operations for Insight Molecular Diagnostics (IMDX) over the last 6 years, with Sep 2025 value amounting to -$11.0 million.

  • Insight Molecular Diagnostics' Income from Continuing Operations rose 18.25% to -$11.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$61.3 million, marking a year-over-year decrease of 41.10%. This contributed to the annual value of -$61.0 million for FY2024, which is 142.84% down from last year.
  • Per Insight Molecular Diagnostics' latest filing, its Income from Continuing Operations stood at -$11.0 million for Q3 2025, which was down 12.25% from -$9.8 million recorded in Q2 2025.
  • Insight Molecular Diagnostics' 5-year Income from Continuing Operations high stood at $6.0 million for Q1 2023, and its period low was -$35.7 million during Q4 2021.
  • For the 3-year period, Insight Molecular Diagnostics' Income from Continuing Operations averaged around -$10.3 million, with its median value being -$9.1 million (2024).
  • Data for Insight Molecular Diagnostics' Income from Continuing Operations shows a peak YoY increase of 157.90% (in 2023) and a maximum YoY decrease of 510.92% (in 2023) over the last 5 years.
  • Quarterly analysis of 5 years shows Insight Molecular Diagnostics' Income from Continuing Operations stood at -$35.7 million in 2021, then skyrocketed by 66.33% to -$12.0 million in 2022, then slumped by 34.63% to -$16.2 million in 2023, then slumped by 107.84% to -$33.6 million in 2024, then rose by 18.25% to -$11.0 million in 2025.
  • Its Income from Continuing Operations stands at -$11.0 million for Q3 2025, versus -$9.8 million for Q2 2025 and -$6.8 million for Q1 2025.